| The value of oligoclonal bands in the multiple sclerosis diagnostic criteria G Arrambide, M Tintore, C Espejo, C Auger, M Castillo, J Río, J Castilló, ... Brain 141 (4), 1075-1084, 2018 | 153 | 2018 |
| COVID‐19 in multiple sclerosis patients: susceptibility, severity risk factors and serological response A Zabalza, S Cárdenas‐Robledo, P Tagliani, G Arrambide, ... European journal of neurology 28 (10), 3384-3395, 2021 | 141 | 2021 |
| Spinal cord lesions: a modest contributor to diagnosis in clinically isolated syndromes but a relevant prognostic factor G Arrambide, A Rovira, J Sastre-Garriga, C Tur, J Castilló, J Río, ... Multiple Sclerosis Journal 24 (3), 301-312, 2018 | 105 | 2018 |
| The long-term outcomes of CIS patients in the Barcelona inception cohort: Looking back to recognize aggressive MS M Tintore, G Arrambide, S Otero-Romero, P Carbonell-Mirabent, J Río, ... Multiple Sclerosis Journal 26 (13), 1658-1669, 2020 | 64 | 2020 |
| Association of early progression independent of relapse activity with long-term disability after a first demyelinating event in multiple sclerosis C Tur, P Carbonell-Mirabent, Á Cobo-Calvo, S Otero-Romero, ... JAMA neurology 80 (2), 151-160, 2023 | 56 | 2023 |
| Contribution of the symptomatic lesion in establishing MS diagnosis and prognosis M Tintore, S Otero-Romero, J Río, G Arrambide, B Pujal, C Tur, I Galán, ... Neurology 87 (13), 1368-1374, 2016 | 56 | 2016 |
| Effect of changes in MS diagnostic criteria over 25 years on time to treatment and prognosis in patients with clinically isolated syndrome M Tintore, A Cobo-Calvo, P Carbonell, G Arrambide, S Otero-Romero, ... Neurology 97 (17), e1641-e1652, 2021 | 46 | 2021 |
| Optic nerve topography in multiple sclerosis diagnosis: the utility of visual evoked potentials A Vidal-Jordana, A Rovira, G Arrambide, S Otero-Romero, J Río, ... Neurology 96 (4), e482-e490, 2021 | 37 | 2021 |
| Lesion topographies in multiple sclerosis diagnosis: a reappraisal G Arrambide, M Tintore, C Auger, J Río, J Castilló, A Vidal-Jordana, ... Neurology 89 (23), 2351-2356, 2017 | 30 | 2017 |
| The frequency and characteristics of MS misdiagnosis in patients referred to the multiple sclerosis centre of Catalonia L Midaglia, J Sastre-Garriga, A Pappolla, L Quibus, R Carvajal, ... Multiple Sclerosis Journal 27 (6), 913-921, 2021 | 22 | 2021 |
| Consensus document on the multidisciplinary management of neurogenic lower urinary tract dysfunction in patients with multiple sclerosis J Medina‐Polo, JM Adot, M Allué, S Arlandis, P Blasco, B Casanova, ... Neurourology and urodynamics 39 (2), 762-770, 2020 | 21 | 2020 |
| The kappa free light chain index and oligoclonal bands have a similar role in the McDonald criteria G Arrambide, C Espejo, P Carbonell-Mirabent, R Dieli-Crimi, ... Brain 145 (11), 3931-3942, 2022 | 19 | 2022 |
| Humoral and cellular responses to SARS-CoV-2 in convalescent COVID-19 patients with multiple sclerosis A Zabalza, G Arrambide, P Tagliani, S Cárdenas-Robledo, ... Neurology: Neuroimmunology & Neuroinflammation 9 (2), e1143, 2022 | 18 | 2022 |
| Simultaneous CMV and Listeria infection following alemtuzumab treatment for multiple sclerosis A Pappolla, L Midaglia, CP Boix Rodríguez, AA Puig, M Lung, IR Camps, ... Neurology 92 (6), 296-298, 2019 | 17 | 2019 |
| Menopause does not modify disability trajectories in a longitudinal cohort of women with clinically isolated syndrome and multiple sclerosis followed from disease onset S Otero‐Romero, L Midaglia, P Carbonell‐Mirabent, M Zuluaga, I Galán, ... European Journal of Neurology 29 (4), 1075-1081, 2022 | 15 | 2022 |
| Is humoral and cellular response to SARS-CoV-2 vaccine modified by DMT in patients with multiple sclerosis and other autoimmune diseases? A Zabalza, G Arrambide, S Otero-Romero, A Pappolla, P Tagliani, ... Multiple Sclerosis Journal 28 (7), 1138-1145, 2022 | 14 | 2022 |
| Association of very early treatment initiation with the risk of long-term disability in patients with a first demyelinating event A Cobo-Calvo, C Tur, S Otero-Romero, P Carbonell-Mirabent, M Ruiz, ... Neurology 101 (13), e1280-e1292, 2023 | 13 | 2023 |
| Treatment response scoring systems to assess long-term prognosis in self-injectable DMTs relapsing–remitting multiple sclerosis patients J Río, À Rovira, C Gasperini, M Tintoré, L Prosperini, S Otero-Romero, ... Journal of Neurology, 1-8, 2022 | 11 | 2022 |
| Oral contraceptives do not modify the risk of a second attack and disability accrual in a prospective cohort of women with a clinically isolated syndrome and early multiple … S Otero-Romero, P Carbonell-Mirabent, L Midaglia, M Zuluaga, I Galán, ... Multiple Sclerosis Journal 28 (6), 950-957, 2022 | 7 | 2022 |
| Optic neuritis: aetiopathogenesis, diagnosis, prognosis and management B Rodríguez-Acevedo, A Rovira, A Vidal-Jordana, D Moncho, D Pareto, ... Revista de neurologia 74 (3), 93-104, 2022 | 6 | 2022 |
